Stallion India Fluorochemicals Secures Land for R-32 Facility Expansion
Stallion India Fluorochemicals has secured a 28,650 sq. meter industrial plot from RIICO to support its R-32 manufacturing facility expansion. Construction for the R-32 plant, with a capacity of 10,000 MT per annum, is underway and expected to be commissioned by August 2026. The facility is projected to generate ₹500 crore in annual revenues with 22-24% PAT margins.
The acquisition of land and commencement of construction for a new manufacturing facility represent a significant expansion for the company, with substantial projected revenues and a positive impact on future growth.
The company has secured land for expansion and received environmental clearance for a new manufacturing facility, which is expected to generate significant revenue and contribute to growth targets.
Stallion India Fluorochemicals Limited (SIFL) has been allotted an industrial plot of approximately 28,650 square meters by Rajasthan State Industrial Development & Investment Corporation Limited (RIICO) under its Direct Allotment Policy-2025. This plot is adjacent to the company's existing facilities in the RIICO Industrial Area, Ukhaliya, Rajasthan.
This land acquisition is a significant step in SIFL's long-term expansion strategy and follows the recent Environmental Clearance (EC) received from the State Environment Impact Assessment Authority (SEIAA), Rajasthan, for its greenfield R-32 manufacturing facility. The approved capacity for this facility is 10,000 MT per annum, with an additional capacity of 7,500 MT per annum for manufacturing blended refrigerants. Hydrochloric Acid (HCl – 30%) will be generated as a by-product.
Mr. Shazad Rustomji, Managing Director & CEO of SIFL, stated that construction activities for the R-32 plant in Bhilwara have commenced and are expected to be completed within seven months, with commercial commissioning targeted by August 2026. The additional land will support future scalability and infrastructure needs, reinforcing the company's focus on backward integration and supply chain resilience. This expansion aligns with the 'Make in India' and 'Viksit Bharat' initiatives. The R-32 facility is projected to generate annual revenues of approximately ₹500 crore with Profit After Tax (PAT) margins between 22–24%. The company has set a 3-year revenue CAGR guidance of 30–35% supported by this expansion.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.